AbbVie Inc. vs Merck & Co., Inc.
AbbVie Inc. is worth $464.575B, 1.2× the $377.724B market cap of Merck & Co., Inc.. Updated daily.
| Metric | AbbVie Inc.ABBV  | |
|---|---|---|
| Market cap | $464.575B | $377.724B |
| Global rank | #1 | #2 |
| Share price | $262.90 | $153.10 |
| Change | +5.12% | +17.39% |
| Revenue | $61.160B | $65.011B |
| Net income | $4.226B | $18.254B |
| Country | United States | United States |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is AbbVie Inc. bigger than Merck & Co., Inc.?
- AbbVie Inc. has a market cap of $464.575B against $377.724B for Merck & Co., Inc., making it 1.2 times as valuable.
- Which company earns more, ABBV or MRK?
- AbbVie Inc. reported net income of $4.226B and Merck & Co., Inc. reported $18.254B in their most recent annual periods.